Evaluation of RevA, a Fibronectin-Binding Protein of Borrelia burgdorferi, as a Potential Vaccine Candidate for Lyme Disease

  • Angela M. Floden, Tammy Gonzalez, Robert A. Gaultney, Catherine A. Brissette
  • Clinical and Vaccine Immunology, April 2013, ASM Journals
  • DOI: 10.1128/cvi.00758-12

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Catherine A Brissette